US Stock MarketDetailed Quotes

AEON AEON Biopharma

Watchlist

0.544
+0.009+1.61%

Close Nov 29 13:00 ET

0.557
+0.013+2.45%

Post 16:31 ET

21.74MMarket Cap1.58P/E (TTM)

AEON Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(FY)Dec 31, 2021

Total revenue

Operating revenue

--0

----

--0

Cost of revenue

Gross profit

Operating expense

4.02M

-44.46%7.76M

-20.43%10.38M

13.97M

13.05M

31.31%48.43M

15.03M

9.91M

95.08%36.88M

Selling and administrative expenses

--3.04M

-32.85%3.32M

21.04%4.65M

----

--4.95M

--3.84M

22.61%13.68M

--5.5M

--2.44M

-3.75%11.15M

Research and development costs

--972K

-50.81%4.44M

-37.73%5.73M

----

--9.03M

--9.21M

35.08%34.75M

--9.53M

--7.48M

251.52%25.73M

Operating profit

-4.02M

44.46%-7.76M

20.43%-10.38M

-13.97M

-13.05M

-31.31%-48.43M

-15.03M

-9.91M

-125.05%-36.88M

Net non-operating interest income expense

Other net income (expense)

-2.16M

12,306.82%171.87M

-2,243.50%-107.64M

-1.41M

-4.59M

78.00%-4.13M

-19.53M

-525K

-13.60%-18.76M

Gain on sale of security

---296K

--8.81M

---43.82M

----

Special income (charges)

--0

--161.23M

---63.77M

----

--0

-160.91%-28.97M

-Less：Restructuring and merger&acquisition

--0

---161.23M

--63.77M

----

--0

----

-Less:Other special charges

----

160.91%28.97M

Other non- operating income (expenses)

---1.86M

229.90%1.83M

98.95%-48K

----

---1.41M

---4.59M

-140.42%-4.13M

---19.53M

---525K

281.87%10.21M

Income before tax

-6.17M

1,167.12%164.11M

-569.07%-118.02M

-15.38M

-17.64M

5.54%-52.56M

-34.56M

-10.44M

-69.04%-55.64M

Income tax

Net income

-6.17M

1,167.12%164.11M

-569.07%-118.02M

-15.38M

-17.64M

5.54%-52.56M

-34.56M

-10.44M

-69.04%-55.64M

Net income continuous Operations

---6.17M

1,167.12%164.11M

-569.07%-118.02M

----

---15.38M

---17.64M

5.54%-52.56M

---34.56M

---10.44M

-69.04%-55.64M

Minority interest income

Net income attributable to the parent company

-6.17M

1,167.12%164.11M

-569.07%-118.02M

-15.38M

-17.64M

5.54%-52.56M

-34.56M

-10.44M

-69.04%-55.64M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-6.17M

1,167.12%164.11M

-569.07%-118.02M

-15.38M

-17.64M

5.54%-52.56M

-34.56M

-10.44M

-102.73%-55.64M

Basic earnings per share

-0.17

852.70%4.22

-295.30%-3.17

-0.5606

-0.8019

5.54%-2.3893

-1.5713

-0.4745

-36.72%-2.5294

Diluted earnings per share

-0.24

852.70%4.22

-295.30%-3.17

-0.5606

-0.8019

5.54%-2.3893

-1.5713

-0.4745

-36.72%-2.5294

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(FY)Dec 31, 2021
Total revenue	0	0	0		0	0	0	0	0	0
Operating revenue	--0	--0	--0	----	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	4.02M	-44.46%7.76M	-20.43%10.38M		13.97M	13.05M	31.31%48.43M	15.03M	9.91M	95.08%36.88M
Selling and administrative expenses	--3.04M	-32.85%3.32M	21.04%4.65M	----	--4.95M	--3.84M	22.61%13.68M	--5.5M	--2.44M	-3.75%11.15M
Research and development costs	--972K	-50.81%4.44M	-37.73%5.73M	----	--9.03M	--9.21M	35.08%34.75M	--9.53M	--7.48M	251.52%25.73M
Operating profit	-4.02M	44.46%-7.76M	20.43%-10.38M		-13.97M	-13.05M	-31.31%-48.43M	-15.03M	-9.91M	-125.05%-36.88M
Net non-operating interest income expense
Other net income (expense)	-2.16M	12,306.82%171.87M	-2,243.50%-107.64M		-1.41M	-4.59M	78.00%-4.13M	-19.53M	-525K	-13.60%-18.76M
Gain on sale of security	---296K	--8.81M	---43.82M	----	----	----	----	----	----	----
Special income (charges)	--0	--161.23M	---63.77M	----	--0	--0	--0	--0	--0	-160.91%-28.97M
-Less：Restructuring and merger&acquisition	--0	---161.23M	--63.77M	----	--0	--0	--0	--0	--0	----
-Less:Other special charges	----	----	----	----	----	----	----	----	----	160.91%28.97M
Other non- operating income (expenses)	---1.86M	229.90%1.83M	98.95%-48K	----	---1.41M	---4.59M	-140.42%-4.13M	---19.53M	---525K	281.87%10.21M
Income before tax	-6.17M	1,167.12%164.11M	-569.07%-118.02M		-15.38M	-17.64M	5.54%-52.56M	-34.56M	-10.44M	-69.04%-55.64M
Income tax	0	0	0		0	0	0	0	0	0
Net income	-6.17M	1,167.12%164.11M	-569.07%-118.02M		-15.38M	-17.64M	5.54%-52.56M	-34.56M	-10.44M	-69.04%-55.64M
Net income continuous Operations	---6.17M	1,167.12%164.11M	-569.07%-118.02M	----	---15.38M	---17.64M	5.54%-52.56M	---34.56M	---10.44M	-69.04%-55.64M
Minority interest income
Net income attributable to the parent company	-6.17M	1,167.12%164.11M	-569.07%-118.02M		-15.38M	-17.64M	5.54%-52.56M	-34.56M	-10.44M	-69.04%-55.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-6.17M	1,167.12%164.11M	-569.07%-118.02M		-15.38M	-17.64M	5.54%-52.56M	-34.56M	-10.44M	-102.73%-55.64M
Basic earnings per share	-0.17	852.70%4.22	-295.30%-3.17		-0.5606	-0.8019	5.54%-2.3893	-1.5713	-0.4745	-36.72%-2.5294
Diluted earnings per share	-0.24	852.70%4.22	-295.30%-3.17		-0.5606	-0.8019	5.54%-2.3893	-1.5713	-0.4745	-36.72%-2.5294
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data